Balyasny Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,151,518
| Closed | -$78.4M | – | 3066 |
|
|
2022
Q3 | $78.4M | Buy |
+1,151,518
| New | +$78.4M | 0.24% | 68 |
|
|
2022
Q1 | – | Sell |
-104,154
| Closed | -$3.05M | – | 2669 |
|
|
2021
Q4 | $3.05M | Buy |
+104,154
| New | +$3.05M | 0.01% | 868 |
|
|
2019
Q2 | – | Sell |
-172,948
| Closed | -$9.15M | – | 1627 |
|
|
2019
Q1 | $9.15M | Sell |
172,948
-22,645
| -12% | -$1.2M | 0.06% | 368 |
|
|
2018
Q4 | $8.03M | Buy |
195,593
+188,991
| +2,863% | +$7.76M | 0.06% | 369 |
|
|
2018
Q3 | $251K | Sell |
6,602
-41,972
| -86% | -$1.6M | ﹤0.01% | 1322 |
|
|
2018
Q2 | $2.2M | Sell |
48,574
-44,146
| -48% | -$2M | 0.01% | 751 |
|
|
2018
Q1 | $4.48M | Buy |
+92,720
| New | +$4.48M | 0.02% | 617 |
|
|
2017
Q4 | – | Sell |
-8,677
| Closed | -$269K | – | 2071 |
|
|
2017
Q3 | $269K | Buy |
+8,677
| New | +$269K | ﹤0.01% | 1376 |
|
|
2016
Q2 | – | Sell |
-30,300
| Closed | -$481K | – | 1303 |
|
|
2016
Q1 | $481K | Buy |
+30,300
| New | +$481K | ﹤0.01% | 698 |
|